North America Pharmaceuticals & Healthcare Views

Pages

ERYTECH's Graspa Gains FDA ODD For AML

ERYTECH Pharma's lead product Graspa (erythrocyte-encapsulated L-asparaginase; ERY-ASP) has been granted orphan drug designation (ODD) by the FDA for the treatment of acute myeloid leukaemia (AML).

Read article ›
Agenus Completes 4-Antibody Acquisition

Agenus, a company developing novel immunotherapeutics, including a portfolio of checkpoint modulators (CPMs), anticancer vaccines and adjuvants, has completed its previously announced acquisition of...

Read article ›
Apricus' Vitaros Approved In Italy

Apricus Biosciences has reported that the Italian Medicines Agency (AIFA) has apprved Vitaros (alprostadil), indicated for the treatment of patients with erectile dysfunction (ED). The company has...

Read article ›

Pages